Molecular Mechanisms of Breast Cancer Metastasis and Potential Anti-metastatic Compounds

被引:36
作者
Tungsukruthai, Sucharat [1 ,2 ]
Petpiroon, Nalinrat [2 ,3 ]
Chanvorachote, Pithi [2 ,3 ]
机构
[1] Chulalongkorn Univ, Interdisciplinary Program Pharmacol, Grad Sch, Bangkok, Thailand
[2] Chulalongkorn Univ, Cell Based Drug & Hlth Prod Dev Res Unit, Bangkok, Thailand
[3] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Pharmacol & Physiol, Bangkok, Thailand
关键词
Breast cancer; metastasis; anti-metastasis compounds; natural product; review; ENDOTHELIAL GROWTH-FACTOR; TUMOR-CELL INVASION; CURCUMIN SUPPRESSES; PI3K/AKT/MTOR PATHWAY; EXTRACELLULAR-MATRIX; SIGNALING PATHWAY; VEGF EXPRESSION; DOWN-REGULATION; NURSES HEALTH; CYCLE ARREST;
D O I
10.21873/anticanres.12502
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Throughout the world, breast cancer is among the major causes of cancer-related death and is the most common cancer found in women. The development of cancer molecular knowledge has surpassed the novel concept of cancer biology and unraveled principle targets for anticancer drug developments and treatment strategies. Metastatic breast cancer cells acquire their aggressive features through several mechanisms, including augmentation of survival, proliferation, tumorigenicity, and motility-related cellular pathways. Clearly, natural product-derived compounds have since long been recognized as an important source for anticancer drugs, several of which have been shown to have promising anti-metastasis activities by suppressing key molecular features supporting such cell aggressiveness. This review provides the essential details of breast cancer, the molecular-based insights into metastasis, as well as the effects and mechanisms of potential compounds for breast cancer therapeutic approaches. As the abilities of cancer cells to invade and metastasize are addressed as the hallmarks of cancer, compounds possessing anti-metastatic effects, together with their defined molecular drug action could benefit the development of new drugs as well as treatment strategies.
引用
收藏
页码:2607 / 2618
页数:12
相关论文
共 105 条
[21]   Improvement of survival and prospect of cure in patients with metastatic breast cancer [J].
Cheng, Yee Chung ;
Ueno, Naoto T. .
BREAST CANCER, 2012, 19 (03) :191-199
[22]   Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction [J].
Choudhuri, T ;
Pal, S ;
Agwarwal, ML ;
Das, T ;
Sa, G .
FEBS LETTERS, 2002, 512 (1-3) :334-340
[23]   FAMILY HISTORY, AGE, AND RISK OF BREAST-CANCER - PROSPECTIVE DATA FROM THE NURSES HEALTH STUDY [J].
COLDITZ, GA ;
WILLETT, WC ;
HUNTER, DJ ;
STAMPFER, MJ ;
MANSON, JE ;
HENNEKENS, CH ;
ROSNER, BA ;
SPEIZER, FE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (03) :338-343
[24]  
Crowe DL, 1999, HISTOL HISTOPATHOL, V14, P665, DOI 10.14670/HH-14.665
[25]   Molecular Mechanisms of Anti-metastatic Activity of Curcumin [J].
Deng, Yi ;
Verron, Elise ;
Rohanizadeh, Ramin .
ANTICANCER RESEARCH, 2016, 36 (11) :5639-5647
[26]   The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM [J].
Edge, Stephen B. ;
Compton, Carolyn C. .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (06) :1471-1474
[27]   Targeting PI3K signalling in cancer: opportunities, challenges and limitations [J].
Engelman, Jeffrey A. .
NATURE REVIEWS CANCER, 2009, 9 (08) :550-562
[28]  
Ferlini Cristiano, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P133, DOI 10.2174/1568011033353489
[29]   Clinical applications of angiogenic growth factors and their inhibitors [J].
Ferrara, N ;
Alitalo, K .
NATURE MEDICINE, 1999, 5 (12) :1359-1364
[30]   Tube travel: The role of proteases in individual and collective a cancer cell invasion [J].
Friedl, Peter ;
Wolf, Katarina .
CANCER RESEARCH, 2008, 68 (18) :7247-7249